Christopher Gibson - 03 Nov 2022 Form 4 Insider Report for RECURSION PHARMACEUTICALS, INC. (RXRX)

Role
Chief Executive Officer, Director
Signature
/s/ Jonathan Golightly, attorney-in-fact
Issuer symbol
RXRX
Transactions as of
03 Nov 2022
Net transactions value
-$314,700
Form type
4
Filing time
04 Nov 2022, 18:39:54 UTC
Previous filing
07 Oct 2022
Next filing
17 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RXRX Class A Common Stock Options Exercise $77,500 +31,250 +5.6% $2.48 594,209 03 Nov 2022 Direct F1
transaction RXRX Class A Common Stock Sale $179,911 -18,193 -3.1% $9.89 576,016 03 Nov 2022 Direct F1, F2
transaction RXRX Class A Common Stock Conversion of derivative security $0 +18,500 +3.2% $0.000000 594,516 03 Nov 2022 Direct F1, F3
transaction RXRX Class A Common Stock Sale $187,037 -18,500 -3.1% $10.11 576,016 03 Nov 2022 Direct F1, F4
transaction RXRX Class A Common Stock Conversion of derivative security $0 +500 $0.000000 500 03 Nov 2022 by LAHWRAN-3 LLC F1, F3, F5
transaction RXRX Class A Common Stock Sale $5,055 -500 -100% $10.11 0 03 Nov 2022 by LAHWRAN-3 LLC F1, F5, F6
transaction RXRX Class A Common Stock Conversion of derivative security $0 +1,000 $0.000000 1,000 03 Nov 2022 by LAHWRAN-4 LLC F1, F3, F7
transaction RXRX Class A Common Stock Sale $10,098 -1,000 -100% $10.10 0 03 Nov 2022 by LAHWRAN-4 LLC F1, F7, F8
transaction RXRX Class A Common Stock Conversion of derivative security $0 +1,000 $0.000000 1,000 03 Nov 2022 by Gibson Family Trust F1, F3, F9
transaction RXRX Class A Common Stock Sale $10,099 -1,000 -100% $10.10 0 03 Nov 2022 by Gibson Family Trust F1, F9, F10

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RXRX Class B Common Stock Conversion of derivative security $0 -18,500 -0.28% $0.000000 6,695,834 03 Nov 2022 Class A Common Stock 18,500 $0.000000 Direct F1, F3, F11
transaction RXRX Stock Option (Right to Buy) Options Exercise $0 -31,250 -3.7% $0.000000 812,500 03 Nov 2022 Class A Common Stock 31,250 $2.48 Direct F1, F13
transaction RXRX Class B Common Stock Conversion of derivative security $0 -500 -0.09% $0.000000 541,000 03 Nov 2022 Class A Common Stock 500 $0.000000 by LAHWRAN-3 LLC F1, F3, F5, F11
transaction RXRX Class B Common Stock Conversion of derivative security $0 -1,000 -0.19% $0.000000 532,000 03 Nov 2022 Class A Common Stock 1,000 $0.000000 by LAHWRAN-4 LLC F1, F3, F7, F11
transaction RXRX Class B Common Stock Conversion of derivative security $0 -1,000 -0.77% $0.000000 128,875 03 Nov 2022 Class A Common Stock 1,000 $0.000000 by Gibson Family Trust F1, F3, F9, F11
holding RXRX Stock Option (Right to Buy) 416,350 03 Nov 2022 Class A Common Stock 0 $11.40 Direct F12
holding RXRX Stock Option (Right to Buy) 5,436 03 Nov 2022 Class A Common Stock 0 $11.40 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2 This transaction was executed in multiple trades at prices ranging from $9.88 to $10.06. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F3 Represents the conversion of Class B Common Stock into Class A Common Stock.
F4 This transaction was executed in multiple trades at prices ranging from $9.88 to $10.45. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F5 The shares are held by LAHWRAN-3 LLC, of which the Reporting Person is a member and a manager.
F6 This transaction was executed in multiple trades at prices ranging from $9.93 to $10.41. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F7 The shares are held by LAHWRAN-4 LLC, of which the Reporting Person is a member and a manager.
F8 This transaction was executed in multiple trades at prices ranging from $9.88 to $10.41. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F9 The shares are held by the Gibson Family Trust, of which the Reporting Person serves as Trustee.
F10 This transaction was executed in multiple trades at prices ranging from $9.88 to $10.41. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F11 Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.
F12 The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2022, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
F13 The option, originally for 1,500,000 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on January 31, 2021, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.